| (19) |
 |
|
(11) |
EP 1 775 342 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
published in accordance with Art. 158(3) EPC |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
20.06.2007 Bulletin 2007/25 |
| (43) |
Date of publication: |
|
18.04.2007 Bulletin 2007/16 |
| (22) |
Date of filing: 28.04.2005 |
|
| (51) |
International Patent Classification (IPC):
|
| (86) |
International application number: |
|
PCT/JP2005/008124 |
| (87) |
International publication number: |
|
WO 2006/001120 (05.01.2006 Gazette 2006/01) |
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI
SK TR |
| (30) |
Priority: |
24.06.2004 JP 2004187028
29.10.2004 WO PCT/JP2004/016089
|
| (71) |
Applicant: DNAVEC Research, Inc. |
|
Tsukuba-shi,
Ibaraki 305-0856 (JP) |
|
| (72) |
Inventors: |
|
- OKANO, Shinji,
15-3-301, Yoshizuka 4-chome,
Fukuoka-shi,
Fukuoka 8120041 (JP)
- YONEMITSU, Yoshikazu
8130043 (JP)
- SUEISHI, Katsuo
8150073 (JP)
- SHIBATA, Satoko
Fukuoka-shi,
Fukuoka 8120061 (JP)
- HASEGAWA, Mamoru,
c/o DNAVEC RESEARCH INC.,
Tsukuba-shi,
Ibaraki 3050856 (JP)
- KONDO, Haruhiko,
4-1303, Urbane Rivie Shimizu,
Fukuoka-shi,
Fukuoka 8150031 (JP)
|
| (74) |
Representative: Vossius & Partner |
|
Siebertstrasse 4
81675 München
81675 München (DE) |
|
| |
|
| (54) |
ANTICANCER AGENT CONTAINING MINUS-STRAND RNA VIRUS |
(57) Minus-strand RNA viruses were found to have an effective tumor-suppressive effect
even when they did not carry a therapeutically effective gene. The present invention
provides anticancer agents comprising a minus-strand RNA virus. Furthermore, the present
invention provides methods for producing the anticancer agents, which comprise the
step of mixing a minus-strand RNA virus with pharmaceutically acceptable carriers.
Furthermore, the present invention provides methods for suppressing cancer, which
comprise the step of administering a minus-strand RNA virus to cancer tissues.